136 related articles for article (PubMed ID: 38501049)
21. Quantitative analyses of myelofibrosis by determining hydroxyproline.
Zhao W; Ho WT; Zhao ZJ
Stem Cell Investig; 2015; 2():2. PubMed ID: 27358870
[TBL] [Abstract][Full Text] [Related]
22. [The development of myelofibrosis in prefibrotic cIMF. An investigation of the progression by sequential bone marrow biopsies in 38 patients].
Buhr T; Länger F; Kreft A; Büsche G; Choritz H; Kreipe H
Pathologe; 2002 Nov; 23(6):433-7. PubMed ID: 12436296
[TBL] [Abstract][Full Text] [Related]
23. Primary myelofibrosis and its targeted therapy.
Shantzer L; Berger K; Pu JJ
Ann Hematol; 2017 Apr; 96(4):531-535. PubMed ID: 27539616
[TBL] [Abstract][Full Text] [Related]
24. Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines.
Bock O; Höftmann J; Theophile K; Hussein K; Wiese B; Schlué J; Kreipe H
Am J Pathol; 2008 Apr; 172(4):951-60. PubMed ID: 18349123
[TBL] [Abstract][Full Text] [Related]
25. Endothelial-to-Mesenchymal Transition in Bone Marrow and Spleen of Primary Myelofibrosis.
Erba BG; Gruppi C; Corada M; Pisati F; Rosti V; Bartalucci N; Villeval JL; Vannucchi AM; Barosi G; Balduini A; Dejana E
Am J Pathol; 2017 Aug; 187(8):1879-1892. PubMed ID: 28728747
[TBL] [Abstract][Full Text] [Related]
26. TGF-β signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche.
Yao JC; Oetjen KA; Wang T; Xu H; Abou-Ezzi G; Krambs JR; Uttarwar S; Duncavage EJ; Link DC
J Clin Invest; 2022 Jun; 132(11):. PubMed ID: 35439167
[TBL] [Abstract][Full Text] [Related]
27. IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis.
Longhitano L; Tibullo D; Vicario N; Giallongo C; La Spina E; Romano A; Lombardo S; Moretti M; Masia F; Coda ARD; Venuto S; Fontana P; Parenti R; Li Volti G; Di Rosa M; Palumbo GA; Liso A
Aging (Albany NY); 2021 Dec; 13(23):25055-25071. PubMed ID: 34905501
[TBL] [Abstract][Full Text] [Related]
28. CDK6 Is a Therapeutic Target in Myelofibrosis.
Dutta A; Nath D; Yang Y; Le BT; Mohi G
Cancer Res; 2021 Aug; 81(16):4332-4345. PubMed ID: 34145036
[TBL] [Abstract][Full Text] [Related]
29. Specific Features of Interactions between Megakaryocytic and Granulocytic Hematopoiesis Lineages and Myelofibrosis during the Acute Phase of Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Dolgikh TY; Senchukova SR; Vinogradova EV; Krinitsyna YM
Bull Exp Biol Med; 2020 Apr; 168(6):734-738. PubMed ID: 32333309
[TBL] [Abstract][Full Text] [Related]
30. Pericyte coverage of abnormal blood vessels in myelofibrotic bone marrows.
Zetterberg E; Vannucchi AM; Migliaccio AR; Vainchenker W; Tulliez M; Dickie R; Hasselbalch H; Rogers R; Palmblad J
Haematologica; 2007 May; 92(5):597-604. PubMed ID: 17488682
[TBL] [Abstract][Full Text] [Related]
31. Platelet-derived growth factor receptor β (PDGFRβ) immunohistochemistry highlights activated bone marrow stroma and is potentially predictive for fibrosis progression in prefibrotic myeloproliferative neoplasia.
Méhes G; Tzankov A; Hebeda K; Anagnostopoulos I; Krenács L; Bedekovics J
Histopathology; 2015 Nov; 67(5):617-24. PubMed ID: 25825163
[TBL] [Abstract][Full Text] [Related]
32. Dengue fever and bone marrow myelofibrosis.
Qing X; Sun N; Yeh J; Yue C; Cai J
Exp Mol Pathol; 2014 Oct; 97(2):208-10. PubMed ID: 25016180
[TBL] [Abstract][Full Text] [Related]
33. [Myelofibrosis caused by cancer: presentation of a clinical case with a very difficult diagnosis].
Fortunato A; Mazzone A; Ricevuti G
Minerva Med; 1985 Aug; 76(32-33):1501-6. PubMed ID: 4034049
[TBL] [Abstract][Full Text] [Related]
34. Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.
Kröger N; Thiele J; Zander A; Schwerdtfeger R; Kobbe G; Bornhäuser M; Bethge W; Schubert J; de Witte T; Kvasnicka HM;
Exp Hematol; 2007 Nov; 35(11):1719-22. PubMed ID: 17976523
[TBL] [Abstract][Full Text] [Related]
35. Recombinant interferon-α in myelofibrosis reduces bone marrow fibrosis, improves its morphology and is associated with clinical response.
Pizzi M; Silver RT; Barel A; Orazi A
Mod Pathol; 2015 Oct; 28(10):1315-23. PubMed ID: 26271725
[TBL] [Abstract][Full Text] [Related]
36. Platelet-derived growth factor receptor β activation and regulation in murine myelofibrosis.
Kramer F; Dernedde J; Mezheyeuski A; Tauber R; Micke P; Kappert K
Haematologica; 2020 Aug; 105(8):2083-2094. PubMed ID: 31672904
[TBL] [Abstract][Full Text] [Related]
37. [Acute or subacute myelofibrosis].
Brière J; Castro-Malaspina H; Brière JF; Bernard J
Nouv Rev Fr Hematol (1978); 1976 Jun; 16(1):3-22. PubMed ID: 951181
[TBL] [Abstract][Full Text] [Related]
38. Multiple myeloma with coexistent myelofibrosis: improvement of myelofibrosis following recovery from multiple myeloma after treatment with melphalan and prednisolone.
Kawauchi K; Mori H; Sugiyama H; Oshimi K; Hirayama A
Jpn J Med; 1991; 30(5):483-6. PubMed ID: 1803051
[TBL] [Abstract][Full Text] [Related]
39. [18F-FDG-PET/CT is effective in distinguishing myelofibrosis due to bone marrow infiltration of diffuse large B-cell lymphoma from triple-negative primary myelofibrosis].
Kumagai T; Satoh Y; Koshiishi M; Ooishi S; Sueki Y; Nakajima K; Mitsumori T; Kirito K
Rinsho Ketsueki; 2017; 58(3):228-232. PubMed ID: 28381690
[TBL] [Abstract][Full Text] [Related]
40. Primary autoimmune myelofibrosis: a case report and review of the literature.
Abaza Y; Yin CC; Bueso-Ramos CE; Wang SA; Verstovsek S
Int J Hematol; 2017 Apr; 105(4):536-539. PubMed ID: 27830539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
